Preclinical News and Research

RSS
Huntington's disease study shows animal models on target

Huntington's disease study shows animal models on target

ZARS starts phase 3 trial of ThermoProfen

ZARS starts phase 3 trial of ThermoProfen

Arius begins toxicology program for lead anti-cancer antibody

Arius begins toxicology program for lead anti-cancer antibody

Affiris alzheimer's vaccine in clinical trial

Affiris alzheimer's vaccine in clinical trial

Suicide gene therapy for cancer

Suicide gene therapy for cancer

Vegetable, fruit and fiber rich - low fat diet, does not appear to reduce breast cancer recurrence

Vegetable, fruit and fiber rich - low fat diet, does not appear to reduce breast cancer recurrence

Researchers identify new combination therapy that promotes cancer cell death

Researchers identify new combination therapy that promotes cancer cell death

Interleukin-6 - new target in the battle against Ras-induced cancers

Interleukin-6 - new target in the battle against Ras-induced cancers

Natural polymer Chitin shows great healing properties

Natural polymer Chitin shows great healing properties

Scientists develop largest ever series of human breasts cancers grafted into mice

Scientists develop largest ever series of human breasts cancers grafted into mice

Neural stem cells for Parkinson's disease

Neural stem cells for Parkinson's disease

Potential role of milk thistle as an anticancer agent

Potential role of milk thistle as an anticancer agent

Catalyst Pharmaceutical Partners starts U.S. phase II trial of CPP-109 in patients with cocaine dependence

Catalyst Pharmaceutical Partners starts U.S. phase II trial of CPP-109 in patients with cocaine dependence

Peregrine licenses worldwide rights to a novel anti-angiogenesis technology

Peregrine licenses worldwide rights to a novel anti-angiogenesis technology

Gene therapy offers promising approach to tackle pancreatic cancer

Gene therapy offers promising approach to tackle pancreatic cancer

Pieris progresses proprietary asthma program

Pieris progresses proprietary asthma program

Biomira files NDA for novel inhibitor of hypoxia-inducible factor-1 alpha

Biomira files NDA for novel inhibitor of hypoxia-inducible factor-1 alpha

New genetic test advances detection and diagnosis of muscular dystrophy

New genetic test advances detection and diagnosis of muscular dystrophy

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer and Onyx submit supplemental NDA for Nexavar

Amphinase molecule from frog could provide first drug treatment for brain tumours

Amphinase molecule from frog could provide first drug treatment for brain tumours

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.